A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
Acadia Healthcare Company, Inc.
ACHC
$3.1B
Mkt Cap
$34.51
+1.47%
Acadia Healthcare Company, Inc. (ACHC) has a 5-year average return on invested capital (ROIC) of -0.2%. This is below average and may indicate limited pricing power.
Acadia Healthcare Company, Inc. (ACHC) has a market capitalization of $3.1B. It is classified as a mid-cap stock.
Acadia Healthcare Company, Inc. (ACHC) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 1.60%.
Acadia Healthcare Company, Inc. (ACHC) operates in the Services-Specialty Outpatient Facilities, Nec industry, within the Healthcare sector.
Acadia Healthcare Company, Inc. (ACHC) reported annual revenue of $3.3 billion in its most recent fiscal year, based on SEC EDGAR filings.
Acadia Healthcare Company, Inc. (ACHC) has a net profit margin of -33.3%. The company is currently unprofitable.
Acadia Healthcare Company, Inc. (ACHC) generated $-440 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
Our business strategy is to become the indispensable behavioral healthcare provider for the high-acuity and complex needs patient population. We are committed to providing the communities we serve with high-quality, cost-effective behavioral healthcare services, while growing our business, increasing profitability and creating long-term value for our stockholders. This strategy includes five growth pathways: expansions of existing facilities, joint venture partnerships, de novo facilities, acquisitions and expansion across our continuum of care. At December 31, 2025, we operated 277 behavioral healthcare facilities with over 12,500 beds in 40 states and Puerto Rico. During the year ended December 31, 2025, we added 1,089 beds, consisting of 311 added to existing facilities and 778 added through the opening of one wholly-owned facility and five joint venture facilities, and we closed five facilities totaling 382 beds.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 3.4B | 3.3B | 3.2B | 2.9B | 2.6B | 2.3B |
| Net Income | -1.1B | -1.1B | 256M | -22M | 273M | 191M |
| EPS | $-12.24 | $-12.16 | $2.78 | $-0.24 | $2.98 | $2.10 |
| Free Cash Flow | -292M | -440M | -561M | 38M | 84M | 130M |
| ROIC | 0.0% | -23.5% | 7.6% | 1.2% | 8.1% | 5.8% |
| Gross Margin | - | - | 24.2% | 11.7% | 26.3% | 24.5% |
| Debt/Equity | 1.29 | 1.36 | 0.68 | 0.54 | 0.54 | 0.65 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | 0 | -938M | 449M | 51M | 437M | 335M |
| Operating Margin | 0.0% | -28.3% | 14.2% | 1.7% | 16.7% | 14.5% |
| ROE | -56.5% | -43.9% | 8.7% | -0.8% | 10.2% | 8.6% |
| Shares Outstanding | 91M | 91M | 92M | 90M | 92M | 91M |
| Metric | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 1.0B | 1.8B | 2.8B | 2.8B | 1.9B | 2.0B | 2.1B | 2.3B | 2.6B | 2.9B | 3.2B | 3.3B | 3.4B |
| Gross Margin | N/A | N/A | N/A | N/A | 22.0% | 22.1% | 25.6% | 24.5% | 26.3% | 11.7% | 24.2% | N/A | N/A |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | 37M | 68M | 87M | 76M | 87M | 90M | 98M | 108M | 124M | 153M | 157M | 178M | 199M |
| EBIT | 215M | 405M | 609M | 604M | 594M | 586M | -473M | 335M | 437M | 51M | 449M | -938M | 0 |
| Op. Margin | 20.9% | 22.1% | 21.7% | 21.3% | 31.2% | 29.2% | -22.7% | 14.5% | 16.7% | 1.7% | 14.2% | -28.3% | 0.0% |
| Net Income | 83M | 113M | 6.1M | 200M | -176M | 109M | -672M | 191M | 273M | -22M | 256M | -1.1B | -1.1B |
| Net Margin | 8.1% | 6.2% | 0.2% | 7.0% | -9.2% | 5.4% | -32.2% | 8.2% | 10.5% | -0.7% | 8.1% | -33.3% | -32.8% |
| Non-Recurring | 814K | 8.5M | -166M | 15M | 326M | 27M | 4.8M | 24M | 0 | 9.7M | 0 | 1.0B | 1.0B |
| Returns on Capital | |||||||||||||
| ROIC | 9.5% | 9.5% | 7.8% | 9.1% | 9.0% | 7.2% | -12.8% | 5.8% | 8.1% | 1.2% | 7.6% | -23.5% | 0.0% |
| ROE | 12.2% | 8.8% | 0.3% | 8.4% | -7.2% | 4.5% | -30.5% | 8.6% | 10.2% | -0.8% | 8.7% | -43.9% | -56.5% |
| ROA | 4.8% | 3.5% | 0.1% | 3.2% | -2.8% | 1.7% | -10.0% | 3.4% | 5.6% | -0.4% | 4.5% | -19.2% | -20.0% |
| Cash Flow | |||||||||||||
| Op. Cash Flow | 115M | 240M | 361M | 400M | 414M | 333M | 659M | 374M | 381M | 462M | 130M | 132M | 182M |
| Free Cash Flow | 2.0M | -36M | 54M | 125M | 161M | 100M | 434M | 130M | 84M | 38M | -561M | -440M | -292M |
| Owner Earnings | 45M | 100M | 119M | 29M | 312M | 228M | 541M | 230M | 233M | 298M | -57M | -89M | -960M |
| CapEx | 113M | 276M | 307M | 274M | 253M | 233M | 225M | 245M | 296M | 424M | 690M | 572M | 474M |
| Maint. CapEx | 61M | 119M | 215M | 347M | 80M | 88M | 95M | 107M | 118M | 132M | 150M | 189M | 1.1B |
| Growth CapEx | 53M | 157M | 93M | 0 | 173M | 145M | 130M | 138M | 178M | 292M | 541M | 383M | 0 |
| D&A | 61M | 119M | 215M | 347M | 80M | 88M | 95M | 107M | 118M | 132M | 150M | 189M | 1.1B |
| CapEx/OCF | 98.2% | 114.8% | 85.1% | 68.6% | 82.5% | 67.6% | 34.1% | 65.4% | 77.8% | 91.7% | 532.3% | 433.5% | 260.4% |
| Capital Allocation | |||||||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 50M | 50M |
| Buyback Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 3.8% | 1.6% |
| Stock-Based Comp | 10M | 20M | 28M | 23M | 22M | 17M | 23M | 38M | 30M | 32M | 37M | 32M | 31M |
| Debt Repayment | 284M | 98M | 201M | 23M | 22M | 77M | 100M | 330M | 95M | 35M | 15M | 1.0B | 1.0B |
| Balance Sheet | |||||||||||||
| Net Debt | 986M | 2.2B | 3.2B | 3.2B | 3.1B | 3.2B | 2.8B | 1.5B | 1.4B | 1.4B | 2.0B | 2.5B | 2.4B |
| Cash & Equiv. | 94M | 11M | 57M | 67M | 51M | 100M | 379M | 134M | 98M | 100M | 76M | 133M | 158M |
| Long-Term Debt | 1.1B | 2.2B | 3.3B | 3.2B | 3.2B | 3.1B | 3.0B | 1.5B | 1.4B | 1.3B | 1.9B | 2.5B | 2.5B |
| Debt/Equity | 1.23 | 1.33 | 1.52 | 1.26 | 1.37 | 1.30 | 1.70 | 0.65 | 0.54 | 0.54 | 0.68 | 1.36 | 1.29 |
| Interest Coverage | 4.5 | 3.8 | 3.4 | 3.4 | 3.2 | 3.1 | -3.0 | 4.4 | 6.3 | 0.6 | 3.9 | -6.8 | -6.8 |
| Equity | 881M | 1.7B | 2.2B | 2.6B | 2.3B | 2.5B | 1.9B | 2.5B | 2.8B | 2.8B | 3.1B | 1.9B | 2.0B |
| Total Assets | 2.2B | 4.3B | 6.0B | 6.4B | 6.2B | 6.9B | 6.5B | 4.8B | 5.0B | 5.4B | 6.0B | 5.5B | 5.5B |
| Total Liabilities | 1.3B | 2.6B | 3.8B | 3.8B | 3.8B | 4.3B | 4.5B | 2.2B | 2.1B | 2.5B | 2.8B | 3.4B | 3.4B |
| Intangibles | 22M | 60M | 83M | 87M | 89M | 69M | 69M | 70M | 76M | 73M | 70M | 97M | 99M |
| Retained Earnings | 101M | 214M | 220M | 429M | 253M | 362M | -310M | -120M | 153M | 132M | 387M | -766M | -762M |
| Working Capital | 108M | 4.5M | 85M | 94M | 34M | 79M | 1.2B | 90M | 118M | -290M | -427K | 289M | 348M |
| Current Assets | 274M | 295M | 428M | 472M | 450M | 542M | 2.5B | 495M | 506M | 596M | 577M | 814M | 837M |
| Current Liabilities | 166M | 290M | 343M | 377M | 416M | 464M | 1.3B | 405M | 388M | 886M | 578M | 525M | 489M |
| Per Share Data | |||||||||||||
| EPS | 1.50 | 1.64 | 0.07 | 2.30 | -2.01 | 1.24 | -7.59 | 2.10 | 2.98 | -0.24 | 2.78 | -12.16 | -12.24 |
| Owner EPS | 0.81 | 1.46 | 1.35 | 0.33 | 3.57 | 2.59 | 6.11 | 2.54 | 2.54 | 3.30 | -0.62 | -0.98 | -10.58 |
| Book Value | 15.91 | 24.52 | 24.70 | 29.61 | 26.69 | 28.52 | 21.45 | 27.73 | 30.69 | 30.82 | 33.43 | 21.49 | 21.58 |
| Cash Flow/Share | 2.08 | 3.50 | 4.12 | 4.60 | 4.74 | 3.79 | 7.44 | 4.13 | 4.15 | 5.12 | 1.41 | 1.45 | 0.04 |
| Dividends/Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 55.4M | 68.6M | 87.8M | 86.9M | 87.4M | 87.8M | 88.6M | 90.8M | 91.7M | 90.3M | 91.9M | 90.7M | 90.8M |
| Valuation | |||||||||||||
| P/E Ratio | 42.0 | 38.0 | 478.3 | 14.2 | N/A | 26.6 | N/A | 28.6 | 27.4 | N/A | 13.7 | N/A | -2.8 |
| P/FCF | N/A | N/A | 54.4 | 22.6 | 13.9 | 28.9 | 9.9 | 42.0 | 88.6 | 184.9 | N/A | N/A | N/A |
| EV/EBIT | 27.1 | 37.0 | 156.9 | 25.1 | N/A | 19.2 | N/A | 23.7 | 20.1 | 167.4 | 12.0 | N/A | N/A |
| Price/Book | 4.0 | 2.5 | 1.4 | 1.1 | 1.0 | 1.2 | 2.3 | 2.2 | 2.7 | 2.5 | 1.1 | 0.7 | 1.6 |
| Price/Sales | 2.7 | 2.6 | 1.6 | 1.3 | 1.1 | 1.3 | 1.3 | 2.3 | 2.5 | 2.3 | 2.0 | 0.7 | 0.9 |
| FCF Yield | 0.1% | -0.8% | 1.8% | 4.4% | 7.2% | 3.5% | 10.1% | 2.4% | 1.1% | 0.5% | -16.1% | -33.0% | -9.3% |
| Market Cap | 3.5B | 4.3B | 2.9B | 2.8B | 2.2B | 2.9B | 4.3B | 5.5B | 7.5B | 7.1B | 3.5B | 1.3B | 3.1B |
| Avg. Price | 49.96 | 69.59 | 51.88 | 42.01 | 37.89 | 30.57 | 30.45 | 59.78 | 72.38 | 74.81 | 67.31 | 25.82 | 34.51 |
| Year-End Price | 62.96 | 62.34 | 33.48 | 32.63 | 25.56 | 32.96 | 48.42 | 60.05 | 81.57 | 78.25 | 37.96 | 14.69 | 34.51 |
Acadia Healthcare Company, Inc. passes 2 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 21.7%. Total shareholder yield (buybacks) is 1.6%. At current prices, the estimated annualized return to fair value is -22.7%.
Acadia Healthcare Company, Inc. (ACHC) has a debt-to-equity ratio of 1.36. This indicates moderate leverage.
Acadia Healthcare Company, Inc. (ACHC) reported earnings per share (EPS) of $-12.16 in its most recent fiscal year.
Acadia Healthcare Company, Inc. (ACHC) has a return on equity (ROE) of -43.9%. A negative ROE may indicate losses or negative equity.
Acadia Healthcare Company, Inc. (ACHC) has a 5-year average gross margin of 21.7%. This lower margin is typical of capital-intensive or commodity businesses.
The Ledger Terminal provides 16 years of financial data for Acadia Healthcare Company, Inc. (ACHC), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Acadia Healthcare Company, Inc. (ACHC) has a book value per share of $21.49, based on its most recent annual SEC filing.